A detailed history of Summit Global Investments transactions in Boston Scientific Corp stock. As of the latest transaction made, Summit Global Investments holds 18,748 shares of BSX stock, worth $1.93 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
18,748
Previous 19,377 3.25%
Holding current value
$1.93 Million
Previous $2.08 Million 12.06%
% of portfolio
0.11%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$97.03 - $108.14 $61,031 - $68,020
-629 Reduced 3.25%
18,748 $1.83 Million
Q2 2025

Aug 12, 2025

BUY
$89.7 - $107.41 $26,910 - $32,223
300 Added 1.57%
19,377 $2.08 Million
Q1 2025

Apr 07, 2025

BUY
$89.38 - $106.18 $1.71 Million - $2.03 Million
19,077 New
19,077 $1.93 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.